A muscle and fat cell protein Cardiotrophin 1 shows promise in treatment of obesity and metabolic syndrome. Metabolic syndrome is characterised by:
Image of Excessive Adipose Tissue in Abdomen
Researchers found that the administration of cardiotrophin 1 accelerates the elimination of fat from the adipose tissue and increases the rate at which fat is burnt in muscles.
Treatment of obese and diabetic mice with cardiotrophin 1;
Cardiotrophin 1 (CT-1) is a member of the interleukin-6 cytokine family. The use of CT-1 in liver transplantation has already been granted Orphan Drug Status by both the FDA and the EMEA.
Let us watch for new developments in this front.
- Obesity,
- Hypertension,
- Diabetes,
- Dyslipidemia, abnormality in lipid or fat level in blood and
- Kidney disease etc.
Image of Excessive Adipose Tissue in Abdomen
Researchers found that the administration of cardiotrophin 1 accelerates the elimination of fat from the adipose tissue and increases the rate at which fat is burnt in muscles.
Treatment of obese and diabetic mice with cardiotrophin 1;
- Iincreased energy expenditure,
- Reduced food intake and
- Corrected obesity and diabetes.
Cardiotrophin 1 (CT-1) is a member of the interleukin-6 cytokine family. The use of CT-1 in liver transplantation has already been granted Orphan Drug Status by both the FDA and the EMEA.
Let us watch for new developments in this front.